World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio (inclisiran) Read more
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor) Read more
Digital applications for on-body devices discussed at Wearable Injectors and Connected Devices conference 2021 Read more
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia Read more
Senhwa’s Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed Read more
Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics’ RheOx System for Chronic Bronchitis Read more